Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.05 – $2.10
20% from low
Exchange
OTC Link
CS
Borrow rate
4.84%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2010 | 2014 | 2015 | 2016 | 2017 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $7.5K | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | 100.0% | — | — | — | — | — | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$246.2K | −$260.7K | −$87.3K | −$1.9K | −$1.2K | −$25.2K | −$16.7K | −$22.8K |
| EBITDA | −$246.2K | −$260.7K | −$87.3K | −$1.9K | −$1.2K | $88.9K | −$16.7K | −$22.8K |
| Net income | −$246.2K | −$260.7K | −$87.3K | −$1.9K | −$1.2K | −$79.0K | −$16.7K | −$22.8K |
| Net margin | -3276.6% | — | — | — | — | — | — | — |
| EPS (diluted) | -0.71 | -0.86 | -0.29 | -0.01 | -0.00 | -0.00 | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
NDT PHARMACEUTICALS INC
No one on the platform currently holds NDTP.
No tracked institution reports a position in NDTP as of their last filing.
No one on the platform has traded NDTP yet.
| +0.00% |
| $66M |
| — |
| IPHYFInnate Pharma S.A. | $1.65 | +0.00% | $155M | — |
| JWCTFJW (Cayman) Therapeutics Co. Ltd | $0.24 | +0.00% | $99M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$NDTP NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion https://finance.yahoo.com/news/ndt-pharmaceuticals-highlights-enhanced-omni-130000625.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr #NDTpharma $AMZN $WMT $CHWY
View on StockTwits ↗$NDTP - The Company’s wholly owned subsidiary, Good Salt Life, Inc., is currently leveraging its presence across some of the world’s largest digital marketplaces, including Amazon, Chewy.com, and Walmart. https://finance.yahoo.com/news/ndt-pharmaceuticals-highlights-enhanced-omni-130000625.html
View on StockTwits ↗$NDTP NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion https://finance.yahoo.com/news/ndt-pharmaceuticals-highlights-enhanced-omni-130000625.html?err=1
View on StockTwits ↗$NDTP News March 03, 2026 NDT Pharmaceuticals Highlights Enhanced Omni-Channel Positioning; Sets Stage for 2026 Growth with Strategic Marketing Expansion https://finance.yahoo.com/news/ndt-pharmaceuticals-highlights-enhanced-omni-130000625.html
View on StockTwits ↗$NDTP - The addition of Dog Gone Odor® to these major e-commerce platforms represents a significant expansion of the Good Salt Life product catalog, which now includes a diverse range of eco-friendly, science-backed solutions for home, pet, and professional environments. Dog Gone Odor® joins other successful brands in the portfolio. https://finance.yahoo.com/news/ndt-pharmaceuticals-inc-wholly-owned-130000615.html
View on StockTwits ↗$NDTP - The product line is scheduled to launch on Chewy.com and Amazon.com in the coming weeks, providing nationwide access to the Company’s EPA-registered antimicrobial solutions. https://finance.yahoo.com/news/ndt-pharmaceuticals-inc-wholly-owned-130000615.html
View on StockTwits ↗$NDTP News January 14, 2026 NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog https://finance.yahoo.com/news/ndt-pharmaceuticals-inc-wholly-owned-130000615.html
View on StockTwits ↗$NDTP - "Receiving Green Seal® certification is more than just a badge for us; it is a testament to the fact that our disinfectant is fundamentally focused on the well-being of the people who use it and the environments they inhabit," said Zach O'Shea, President of NDT Pharmaceuticals, Inc. "We believe that Clean Republic could be used as a hospital-grade disinfectant, appearing to be powerful enough for clinical settings, safe enough for food-contact surfaces and daily use in homes and schools.” https://finance.yahoo.com/news/ndt-pharmaceuticals-inc-wholly-owned-140000822.html
View on StockTwits ↗$NDTP - Green Seal® is considered one of the world’s most respected symbols of environmental and health leadership. To earn the seal, Clean Republic underwent an extensive audit to prove it meets a high standard for performance, reduced toxicity, and environmental impact. https://finance.yahoo.com/news/ndt-pharmaceuticals-inc-wholly-owned-140000822.html
View on StockTwits ↗$NDTP News February 05, 2026 NDT Pharmaceuticals Inc.’s Wholly Owned Subsidiary, Good Salt Life, Receives Official Green Seal® Certification for Clean Republic Multipurpose Disinfectant https://finance.yahoo.com/news/ndt-pharmaceuticals-inc-wholly-owned-140000822.html
View on StockTwits ↗🚨 $NDTP ALERT – OMNI-CHANNEL BEAST MODE UNLOCKED TODAY! 🔥🛒📈 NDT Pharma just dropped: Optimized http://Walmart.com digital storefront for Good Salt Life HOCl products – massive reach boost! Positioning for explosive 2026 growth in $148B biosafety/wellness market. https://finance.yahoo.com/news/ndt-pharmaceuticals-highlights-enhanced-omni-130000625.html Strategic marketing expansion loading – recurring rev potential huge! Stock exploding on volume, low float runner ready for the next leg. Traders: momentum FOMO incoming. Investors: diamond hands on real expansion catalysts. Don't sleep on this one! LFG! 💥🧼 $NDTP #Biosafety #Wellness #PennyStocks #HighAlert @NDTPharma @frontpagestocks
View on StockTwits ↗$NDTP - The Company’s wholly owned subsidiary, Good Salt Life, Inc., is currently leveraging its presence across some of the world’s largest digital marketplaces, including Amazon, Chewy.com, and Walmart. https://finance.yahoo.com/news/ndt-pharmaceuticals-highlights-enhanced-omni-130000625.html
View on StockTwits ↗$NDTP Strategic Investment in Growth: Marketing Team Expansion To further amplify this market presence, NDT Pharmaceuticals is actively scaling its internal marketing and digital growth division, an investment designed to maximize the brand's reach across its expanding retail footprint. Management anticipates that an investment in human capital could advance the Company’s data analytics, customer acquisition cost (CAC) optimization, and cross-platform advertising expenditure.
View on StockTwits ↗$NDTP $1.05's going now. $1.19 HOD! #Bullish
View on StockTwits ↗🚨 $NDTP News - NDT Pharma just dropped: Optimized Walmart.com digital storefront for Good Salt Life HOCl products – massive reach boost! Positioning for explosive 2026 growth in $148B biosafety/wellness market. https://finance.yahoo.com/news/ndt-pharmaceuticals-highlights-enhanced-omni-130000625.html Strategic marketing expansion loading – recurring rev potential huge! Stock exploding on volume, low float runner ready for the next leg. Traders: momentum FOMO incoming. Investors: diamond hands on real expansion catalysts. Don't sleep on this one! LFG! 💥🧼 #NDTP #Biosafety #Wellness #PennyStocks #HighAlert @NDTPharma @frontpagestocks @CrusaderStocks @witchkingstocks @momostockspick @frontpagestocks
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.